Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
100
NCT00861796
Study of CYR-101 in Patients With Schizophrenia
Phase: Phase 2
Role: Lead Sponsor
Start: Mar 31, 2008
Completion: Jun 30, 2010